TITLE

Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic Assessment

AUTHOR(S)
Fryer, Rosemary A.; Graham, Timothy J.; Smith, Emma M.; Walker-Samuel, Simon; Morgan, Gareth J.; Robinson, Simon P.; Davies, Faith E.
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To aid preclinical development of novel therapeutics for myeloma, an in vivo model which recapitulates the human condition is required. An important feature of such a model is the interaction of myeloma cells with the bone marrow microenvironment, as this interaction modulates tumour activity and protects against drug-induced apoptosis. Therefore NOD/SCIDγcnull mice were injected intra-tibially with luciferase-tagged myeloma cells. Disease progression was monitored by weekly bioluminescent imaging (BLI) and measurement of paraprotein levels. Results were compared with magnetic resonance imaging (MRI) and histology. Assessment of model suitability for preclinical drug testing was investigated using bortezomib, melphalan and two novel agents. Cells engrafted at week 3, with a significant increase in BLI radiance occurring between weeks 5 and 7. This was accompanied by an increase in paraprotein secretion, MRI-derived tumour volume and CD138 positive cells within the bone marrow. Treatment with known anti-myeloma agents or novel agents significantly attenuated the increase in all disease markers. In addition, intra-tibial implantation of primary patient plasma cells resulted in development of myeloma within bone marrow. In conclusion, using both myeloma cell lines and primary patient cells, we have developed a model which recapitulates human myeloma by ensuring the key interaction of tumour cells with the microenvironment.
ACCESSION #
87625579

 

Related Articles

  • Mould could defeat bone marrow cancer. Tanday, Sanjay // GP: General Practitioner;4/20/2007, p2 

    The article cites a study conducted by U.S. researchers regarding the use of chaetocin, a byproduct of a common wood mould, to kill multiple myeloma. According to the researchers, chaetocin is structurally similar to anti-cancer agents, and could have potent anti-myeloma properties. The study...

  • Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types. Amend, Sarah R.; Wilson, William C.; Chu, Liang; Lu, Lan; Liu, Pengyuan; Serie, Daniel; Su, Xinming; Xu, Yalin; Wang, Dingyan; Gramolini, Anthony; Wen, Xiao-Yan; O’Neal, Julie; Hurchla, Michelle; Vachon, Celine M.; Colditz, Graham; Vij, Ravi; Weilbaecher, Katherine N.; Tomasson, Michael H. // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Monoclonal gammopathy of undetermined significance (MGUS) is the requisite precursor to multiple myeloma (MM), a malignancy of antibody-producing plasma B-cells. The genetic basis of MGUS and its progression to MM remains poorly understood. C57BL/KaLwRij (KaLwRij) is a spontaneously-derived...

  • A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression. Marty, C; Lacout, C; Droin, N; Le Couédic, J-P; Ribrag, V; Solary, E; Vainchenker, W; Villeval, J-L; Plo, I // Leukemia (08876924);Nov2013, Vol. 27 Issue 11, p2187 

    Although other mutations may predate the acquisition of the JAK2V617F mutation, the latter is sufficient to drive the disease phenotype observed in BCR-ABL-negative myeloproliferative neoplasms (MPNs). One of the consequences of JAK2V617F is genetic instability that could explain...

  • P234 AAV-mediated cardiac transfer of the desmin cDNA ameliorates progression of cardiomyopathy in desmin-deficient mice. Heckmann, M; Bauer, R; Jungmann, A; Strucksberg, KH; Schroeder, R; Katus, HA; Mueller, OJ // Cardiovascular Research;Jul2014, Vol. 103 Issue suppl_1, pS41 

    Background: Desmin is a type III intermediate filament which plays a central role in maintaining the structural integrity of cardiac and skeletal muscle cells. Mutations in the desmin coding gene are associated with a heterogeneous phenotype involving cardiomyopathies, cardiac conduction disease...

  • In Vivo Imaging Demonstrates ATP Release from Murine Keratinocytes and Its Involvement in Cutaneous Inflammation after Tape Stripping. Takahashi, Toshiya; Kimura, Yutaka; Niwa, Kazuki; Ohmiya, Yoshihiro; Fujimura, Taku; Yamasaki, Kenshi; Aiba, Setsuya // Journal of Investigative Dermatology;Oct2013, Vol. 133 Issue 10, p2407 

    Adenosine 5′-triphosphate (ATP) release from keratinocytes has been observed in various stress models in vitro, but studies demonstrating epidermal ATP release in vivo are limited. To visualize extracellular ATP (eATP) in vivo, we developed enhanced green-emitting luciferase immobilized on...

  • Identification of the murine firefly luciferase-specific CD8 T-cell epitopes. Limberis, M. P.; Bell, C. L.; Wilson, J. M. // Gene Therapy;Mar2009, Vol. 16 Issue 3, p441 

    In vivo bioluminescence imaging of reporter enzymes has proven to be a uniquely powerful tool that allows the study of the biology of viral and nonviral gene transfer agents. Cost-effective, noninvasive, longitudinal gene transfer studies in individual animals yield important information, which...

  • Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase. Santos, Elmer B.; Yeh, Raymond; Lee, James; Nikhamin, Yan; Punzalan, Blesida; Punzalan, Blesserene; Perle, Krista La; Larson, Steven M.; Sadelain, Michel; Brentjens, Renier J. // Nature Medicine;Mar2009, Vol. 15 Issue 3, p338 

    We developed a new approach to bioluminescent T cell imaging using a membrane-anchored form of the Gaussia luciferase (GLuc) enzyme, termed extGLuc, which we could stably express in both mouse and human primary T cells. In vitro, extGLuc+ cells emitted significantly higher bioluminescent signal...

  • Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1α. Ueda, Masashi; Kudo, Takashi; Kuge, Yuji; Mukai, Takahiro; Tanaka, Shotaro; Konishi, Hiroaki; Miyano, Azusa; Ono, Masahiro; Kizaka-Kondoh, Shinae; Hiraoka, Masahiro; Saji, Hideo // European Journal of Nuclear Medicine & Molecular Imaging;Aug2010, Vol. 37 Issue 8, p1566 

    Hypoxia-inducible factor-1 (HIF-1) plays an important role in malignant tumour progression. For the imaging of HIF-1-active tumours, we previously developed a protein, POS, which is effectively delivered to and selectively stabilized in HIF-1-active cells, and a radioiodinated biotin derivative,...

  • Highly Sensitive In Vivo Imaging of Trypanosoma brucei Expressing “Red-Shifted” Luciferase. McLatchie, Alex P.; Burrell-Saward, Hollie; Myburgh, Elmarie; Lewis, Michael D.; Ward, Theresa H.; Mottram, Jeremy C.; Croft, Simon L.; Kelly, John M.; Taylor, Martin C. // PLoS Neglected Tropical Diseases;Nov2013, Vol. 7 Issue 11, p1 

    Background: Human African trypanosomiasis is caused by infection with parasites of the Trypanosoma brucei species complex, and threatens over 70 million people in sub-Saharan Africa. Development of new drugs is hampered by the limitations of current rodent models, particularly for stage II...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics